Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Long-Term Debt Issuances (2016)

Historic Long-Term Debt Issuances for Cardiff Oncology (CRDF) over the last 5 years, with Q4 2016 value amounting to -$1.0.

  • Cardiff Oncology's Long-Term Debt Issuances fell 10000.01% to -$1.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$1.0, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of $305000.0 for FY2020, which is N/A changed from last year.
  • As of Q4 2016, Cardiff Oncology's Long-Term Debt Issuances stood at -$1.0, which was down 10000.01% from $7.0 million recorded in Q3 2016.
  • In the past 5 years, Cardiff Oncology's Long-Term Debt Issuances ranged from a high of $14.5 million in Q2 2014 and a low of -$48637.0 during Q1 2014
  • In the last 5 years, Cardiff Oncology's Long-Term Debt Issuances had a median value of $2.3 million in 2012 and averaged $2.7 million.
  • The largest annual percentage gain for Cardiff Oncology's Long-Term Debt Issuances in the last 5 years was 51974.67% (2014), contrasted with its biggest fall of 10208.29% (2014).
  • Over the past 5 years, Cardiff Oncology's Long-Term Debt Issuances (Quarter) stood at $2.3 million in 2012, then changed by 0.0% to $2.3 million in 2013, then plummeted by 77.9% to $515964.0 in 2014, then surged by 110.49% to $1.1 million in 2015, then tumbled by 100.0% to -$1.0 in 2016.
  • Its Long-Term Debt Issuances was -$1.0 in Q4 2016, compared to $7.0 million in Q3 2016 and $241954.0 in Q2 2016.